Ampio Pharmaceuticals News - AMPE

Company Name	Stock Ticker Symbol	Market	Type
Ampio Pharmaceuticals Inc	AMPE	AMEX	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.62	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				0.62

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/03/2024	14:33	PRNUS	Ampio Pharmaceuticals Received Audit Opinion with Going..
3/25/2024	17:00	PRNUS	Ampio Announces Voluntary Delisting and SEC Deregistration
3/05/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2/28/2024	15:49	EDGAR2	Form 8-K - Current report
2/28/2024	15:48	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
2/28/2024	15:47	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
2/28/2024	15:46	EDGAR2	Form POS AM - Post-Effective amendments for registration..
2/28/2024	15:45	EDGAR2	Form RW - Registration Withdrawal Request
2/15/2024	09:31	EDGAR2	Form 8-K - Current report
2/14/2024	17:45	PRNUS	Ampio Provides Update on Results from Pre-IND Enabling..
1/25/2024	16:31	EDGAR2	Form 8-K - Current report
1/25/2024	16:18	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/24/2024	17:16	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/11/2024	16:20	EDGAR2	Form 8-K - Current report
1/11/2024	16:15	PRNUS	Ampio Provides Litigation Update - Reports Settlement in..
12/21/2023	16:25	EDGAR2	Form S-1 - General form for registration of securities under..
11/14/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	09:30	EDGAR2	Form 8-K - Current report
10/31/2023	09:00	PRNUS	Ampio Pharmaceuticals to Present at the Emerging Growth..
10/27/2023	14:10	EDGAR2	Form 8-K - Current report
10/06/2023	14:56	EDGAR2	Form 8-K - Current report
10/05/2023	16:30	PRNUS	Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO..
10/04/2023	16:15	EDGAR2	Form 8-K - Current report
9/26/2023	09:15	PRNUS	Ampio Pharmaceuticals to Present at the Emerging Growth..
9/22/2023	16:30	EDGAR2	Form 8-K - Current report
9/18/2023	16:30	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/31/2023	16:19	EDGAR2	Form 8-K - Current report
8/31/2023	06:30	PRNUS	Ampio Pharmaceuticals Announces Reverse Stock Split
8/15/2023	16:56	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/08/2023	16:32	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/13/2023	11:33	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
7/05/2023	16:37	EDGAR2	Form 8-K - Current report
5/26/2023	16:40	PRNUS	Ampio Pharmaceuticals Announces Series D Preferred Stock..